🇺🇸 FDA
Patent

US 8153642

Quinazolines useful as modulators of ion channels

granted A61PA61P11/00A61P13/02

Quick answer

US patent 8153642 (Quinazolines useful as modulators of ion channels) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Apr 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P11/00, A61P13/02, A61P17/02, A61P19/02